1. Expanding U.S. Supply Options for Large-Volume Parenterals

    Marga Viñes, Business Development Manager, Grifols discusses the company’s vertical integration philosophy.

  2. Building the Foundation of Japan’s Premier CDMO

    Jun Yokohama, President & CEO of Bushu Pharmaceuticals Ltd. and Toshio Yoshioka, President at Spera Pharma, Inc. discuss how the firm helps clients overcome barriers to entry.

  3. Perspectives on Product Pricing Strategy and Practice
    Getting pricing “right” is a tricky balancing act, but one that offers tremendous value for all.
  4. Moving Beyond Monoclonal Antibodies
    Next-generation antibody therapeutics are designed to provide improved specificity, efficacy and safety when compared to conventional monoclonal antibodies.
  5. Becoming Bioavailable

    Poorly soluble molecules in the pipeline can have a negative effect on your active pharmaceutical ingredient (API).

  6. How is the Need to Provide Local Drug-Product Supply in Multiple Regions Around the World Impacting Pharmaceutical Manufacturing Facility and Equipment Design?
    Experts from across the industry lend their thoughts to the Roundtable.
  7. WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang

    The new biologics center will include process development labs, clinical manufacturing facility (MFG9) with 5,000 L bioreactor capacity and commercial manufacturing facility (MFG8) with 48,000 L bioreactor capacity.

  8. Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA

    RETACRIT, the First U.S. Biosimilar Erythropoiesis-Stimulating Agent (ESA), is now approved across all indications.

  9. Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

    The rapid adoption of new cancer immunotherapies raises some concerns.

  10. Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

    Engineered chemical trap detects rare glycoproteins emitted as cancer first develops.

  11. With Expertise Comes Security

    Using a trusted expert to remove surplus equipment helps protect your facility and assets, says Matt Hicks, Chief Operating Officer & Counsel for Federal Equipment Company. 

  12. Differentiating Generic SODFs with Hard Capsule Formulations

    With lower development costs and greater flexibility, hard capsules are the best choice for the formulation of generic solid oral dosage pharmaceuticals, explains Jonathan Gilinski, Executive Director for CapsCanada.

  13. Segregation in the Design of Gene Therapy Manufacturing Facilities
    Peter Walters, Lead Process Engineer for CRB USA explains segregating manufacturing operations.
  14. Designing Flexibility for Added Value

    Peter Cramer, AIA, NCARB, Vice President, Life Science Facility Design at M+W Group explains what biopharmaceutical facilities need to stay valuable and relevant.

  15. Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
    Clint Pepper, Ph.D., Director of MAST Technology at Capsugel, explains the Modular Automated Sampling Technology platform.
  16. Looking forward, what technologies do you anticipate having the greatest impact in 2018?

    Experts weigh in on our Roundtable question.

  17. Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

    Grifols conventional antisera reagents recently received licensing approval by the U.S. Food & Drug Administration for manual testing in immunohematology laboratories.

  18. Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline

    Facilities in the Netherlands and the United States will help advance the manufacturing of cell therapies for cancer patients. 

  19. Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended
    Two additional targets added to initial four, with the potential for an additional $500 million in milestone payments. 
  20. Editas Founders Start New Gene Editing Company

    Beam Therapeutics will focus on a gene editing technique that does not require cutting.

Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
SEARCH COMPANIES
Immunotherapy

Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

May 18, 2018 11:48:11 AM PAO-M05-18-NI-013
Diagnostics

Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

May 18, 2018 11:43:59 AM PAO-M05-18-NI-012
Cell and Gene Therapy

Editas Founders Start New Gene Editing Company

May 17, 2018 12:40:28 PM PAO-M05-18-NI-011
Immunotherapy

Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended

May 17, 2018 12:33:28 PM PAO-M05-18-NI-010
Used Equipment

With Expertise Comes Security

May 17, 2018 9:46:56 AM PA-M05-18-CL-001
Oncology

Roche’s TECENTRIQ (Atezolizumab) Receives Priority Review

May 15, 2018 11:30:45 AM PAO-M05-18-NI-009
Acquisition

Eli Lilly Makes Two Acquisitions in the Oncology Space

May 15, 2018 11:14:39 AM PAO-M05-18-NI-008
Biosimilars

GlobalData Predicts Strong Sales for Humira Biosimilars in Europe

May 10, 2018 2:11:16 PM PAO-M05-18-NI-006
Acquisition

Takeda Acquires Shire for $62 Billion

May 10, 2018 2:03:33 PM PAO-M05-18-NI-005
FDA

New WuXi STA Solid-Dose API Plant Gets Okay from US FDA

May 10, 2018 1:51:20 PM PAO-M05-18-NI-004
Columns

Nice Insight Overview

M&A Activity in a Fragmented CDMO Market
While there has been a slowdown in M&A in the pharmaceutical industry, the contract services market remains highly fragmented and players large and small continue to enhance their competitiveness through inorganic growth.

Roundtable

M&A: What Role has M&A Played in your Company’s Growth?

In Conversation

Operational Excellence in Outsourced Fill-Finish Services
Nice Insight is in conversation with Oskar Gold at Vetter Pharma International, a global leader in the fill-finish of aseptically prefilled syringe systems, cartridges and vials, about how outsourced supply of such services can help companies of all sizes.

In Conversation

M&A: Combining Market Segments

Dago Caceres and Gary Lord, The Dow Chemical Company